Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Eli Lilly beats on quarterly profit, hikes full-year guidance on strong sales of Zepbound, Mounjaro By: CNBC.com News April 30, 2024 at 06:58 AM EDT Zepbound reported $517.4 million in sales for the quarter, even as most doses of the drug slipped into shortages in the U.S. Read More >> Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Eli Lilly beats on quarterly profit, hikes full-year guidance on strong sales of Zepbound, Mounjaro By: CNBC.com News April 30, 2024 at 06:58 AM EDT Zepbound reported $517.4 million in sales for the quarter, even as most doses of the drug slipped into shortages in the U.S. Read More >>